[TVTX] YoY Quarter Result on 30-Jun-2019 [#Q2]

Stock
[TVTX] Travere Therapeutics, Inc.
Announcement Date
06-Aug-2019
Financial Year
2019
Quarter
30-Jun-2019 [#Q2]
Profit Trend
QoQ- 5.55%
YoY- -73.32%
Quarter Report
TVTX's Result
TVTX's Financial Summary
View:
Show?
Quarter Result
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
Revenue 54,167 54,617 48,430 44,707 41,337 38,800 33,311 8.43%
PBT -66,979 -38,963 -26,003 -38,632 -22,162 -15,154 -20,795 21.51%
Tax 53 49 65 69 167 -1,925 -7,392 -
NP -67,032 -39,012 -26,068 -38,701 -22,329 -13,229 -13,403 30.75%
Tax Rate - - - - - - - -
Total Cost 121,199 93,629 74,498 83,408 63,666 52,029 46,714 17.21%
Ratio Analysis
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
NP Margin -123.75 -71.43 -53.83 -86.57 -54.02 -34.10 -40.24 20.58%
Per Share
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
EPS -1.05 -0.64 -0.58 -0.92 -0.56 -0.34 -0.37 18.97%
EPS Diluted -1.05 -0.64 -0.58 -0.92 -0.56 -0.34 -0.37 18.97%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.